Eaton Gets Upgraded, Moderna Targets Rise

Analyst desks were active on Monday, with power management giant ETN earning a consensus upgrade — a rare collective shift for a stock with a $160 billion market cap. The upgrade reflects growing confidence in Eaton's data center and grid electrification exposure.

MRNA saw its average target price climb to $118.6, up from $116.5. The move is notable given short sellers hold 13.4% of Moderna's free float. Bears and bulls are fighting over this name.

NVDA got another target lift, with the consensus average nudging to $327.65. The chip giant collects upgrades like most collect receipts, but the direction stays firmly upward.

Going the other way, AMD had its price target trimmed to $612.6. The cut is modest but notable — AMD's $780 billion valuation leaves little room for error.

AKAM also saw its target reduced to $153.3, from $155.1. Akamai has struggled to excite investors as cloud CDN competition bites.

GD received a target bump to $421.7. Defence spending tailwinds continue to drive analyst optimism in that name.

Retailer TGT edged higher too, with targets raised to $162.8 as analysts cautiously turn more positive on US consumer resilience heading into autumn.